Trop2 CAR-NK cell therapy(Henan Provincial Cancer Hospital)

TROP2-CAR-NK (河南省肿瘤医院)

Report date: 2026/04/14 20:00:15

Base Information

Drug NameTrop2 CAR-NK cell therapy(Henan Provincial Cancer Hospital)

Drug Alias NameAnti-Trop2 Universal CAR-NK(U-CAR-NK) Cells Therapy(Henan Provincial Cancer Hospital)Anti-Trop2 CAR-NK cell Therapy(Henan Provincial Cancer Hospital)

ClassificationCell and gene therapy > Cell therapy > Donor > AllogeneicCell and gene therapy > Cell therapy > Immune system cell therapy > Cytokine-induced killer cell > Chimeric antigen receptor CIK cell therapyCell and gene therapy > Cell therapy > Immune system cell therapy > Lymphocytes therapy > Natural killer cell therapy > Chimeric antigen receptor NK cell therapy > Universal CAR-NK cell therapy

Mechanisms of ActionAnti-Trop-2Natural killer cell replacements

TargetsTumor-associated calcium signal transducer 2

Therapy Area/IndicationsCarcinoma, Non-Small-Cell Lung

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusPhase 2 Clinical

Highest Status in ChinaN/A

Originator CompaniesHenan Provincial Cancer Hospital

China Registration ClassN/A

Develop Information

Active CompaniesHenan Provincial Cancer Hospital

Inactive CompaniesN/A

Active IndicationsCarcinoma, Non-Small-Cell Lung

Inactive IndicationsN/A

Other Information

ATC CodeN/A